The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

Ascendis Pharma (ASND) reported its fourth-quarter 2024 earnings, highlighting a significant revenue increase and a positive market reaction. The company posted total revenue of €173.9 million for the ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.